Skip to content

INOVIO PHARMACEUTICALS, INC.: 10-K filed 2017-03-15

What INOVIO PHARMACEUTICALS, INC. reported in its annual report filed 2017-03-15 (fiscal FY 2016): 48 published measures, 202 facts as tagged in accession 0001055726-17-000013.

This filing

Form
10-K (annual report)
Filed
2017-03-15
Fiscal period
fiscal FY 2016
Accession
0001055726-17-000013 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All INOVIO PHARMACEUTICALS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2016-12-31173,707,166USD
At 2015-12-31213,840,859USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2016-12-3150,328,746USD
At 2015-12-3137,907,806USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2016-12-31123,282,151USD
At 2015-12-31175,687,225USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2016-12-3119,136,472USD
At 2015-12-3157,632,693USD
At 2014-12-3140,543,982USD
At 2013-12-3133,719,796USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2016-01-01 to 2016-12-31-73,740,339USD366
2015-10-01 to 2015-12-31-17,952,045USD92
2015-01-01 to 2015-12-31-29,187,606USD365
2015-07-01 to 2015-09-305,594,468USD92
2015-04-01 to 2015-06-30-6,248,250USD91
2015-01-01 to 2015-03-31-10,581,779USD90
2014-01-01 to 2014-12-31-36,121,713USD365

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2016-01-01 to 2016-12-31-62,555,052USD366
2015-01-01 to 2015-12-31-12,438,901USD365
2014-01-01 to 2014-12-31-29,823,644USD365

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2016-01-01 to 2016-12-312,738,470USD366
2015-01-01 to 2015-12-312,781,544USD365
2014-01-01 to 2014-12-311,379,980USD365

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2016-10-01 to 2016-12-318,513,952USD92
2016-01-01 to 2016-12-3135,368,361USD366
2016-07-01 to 2016-09-3012,540,463USD92
2016-04-01 to 2016-06-306,203,791USD91
2016-01-01 to 2016-03-318,110,155USD91
2015-10-01 to 2015-12-315,935,562USD92
2015-01-01 to 2015-12-3140,572,111USD365
2015-07-01 to 2015-09-3024,183,234USD92
2015-04-01 to 2015-06-305,286,678USD91
2015-01-01 to 2015-03-315,166,637USD90
2014-01-01 to 2014-12-3110,456,766USD365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2016-01-01 to 2016-12-317,786,942USD366
2015-01-01 to 2015-12-3184,351,719USD365
2014-01-01 to 2014-12-3172,461,725USD365

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2016-01-01 to 2016-12-3116,271,889USD366
2015-01-01 to 2015-12-31-54,824,107USD365
2014-01-01 to 2014-12-31-35,812,206USD365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2016-12-31-434,838,235USD
At 2015-12-31-361,097,896USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2016-01-01 to 2016-12-3173,214,766shares366
2015-01-01 to 2015-12-3168,198,142shares365
2014-01-01 to 2014-12-3159,127,349shares365

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2016-01-01 to 2016-12-3173,214,766shares366
2015-01-01 to 2015-12-3168,365,265shares365
2014-01-01 to 2014-12-3159,408,252shares365

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2016-10-01 to 2016-12-31-0.35USD/shares92
2016-01-01 to 2016-12-31-1.01USD/shares366
2016-07-01 to 2016-09-30-0.28USD/shares92
2016-04-01 to 2016-06-30-0.26USD/shares91
2016-01-01 to 2016-03-31-0.11USD/shares91
2015-10-01 to 2015-12-31-0.25USD/shares92
2015-01-01 to 2015-12-31-0.43USD/shares365
2015-07-01 to 2015-09-300.08USD/shares92
2015-04-01 to 2015-06-30-0.09USD/shares91
2015-01-01 to 2015-03-31-0.17USD/shares90
2014-01-01 to 2014-12-31-0.61USD/shares365

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2016-10-01 to 2016-12-31-0.36USD/shares92
2016-01-01 to 2016-12-31-1.01USD/shares366
2016-07-01 to 2016-09-30-0.28USD/shares92
2016-04-01 to 2016-06-30-0.26USD/shares91
2016-01-01 to 2016-03-31-0.11USD/shares91
2015-10-01 to 2015-12-31-0.25USD/shares92
2015-01-01 to 2015-12-31-0.44USD/shares365
2015-07-01 to 2015-09-300.07USD/shares92
2015-04-01 to 2015-06-30-0.09USD/shares91
2015-01-01 to 2015-03-31-0.18USD/shares90
2014-01-01 to 2014-12-31-0.64USD/shares365

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2016-01-01 to 2016-12-310USD366
2015-10-01 to 2015-12-31-308,520USD92
2015-01-01 to 2015-12-31-2,097,766USD365
2015-07-01 to 2015-09-30-1,789,246USD92
2015-04-01 to 2015-06-300USD91
2015-01-01 to 2015-03-310USD90
2014-01-01 to 2014-12-310USD365

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2016-12-319,025,446USD
At 2015-12-317,306,695USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2016-01-01 to 2016-12-3110,479,135USD366
2015-01-01 to 2015-12-316,186,848USD365
2014-01-01 to 2014-12-315,428,946USD365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2016-10-01 to 2016-12-31-22,363,296USD92
2016-01-01 to 2016-12-31-76,235,937USD366
2016-07-01 to 2016-09-30-20,195,483USD92
2016-04-01 to 2016-06-30-18,226,540USD91
2016-01-01 to 2016-03-31-15,450,618USD91
2015-10-01 to 2015-12-31-14,526,415USD92
2015-01-01 to 2015-12-31-34,283,702USD365
2015-07-01 to 2015-09-303,730,417USD92
2015-04-01 to 2015-06-30-15,120,093USD91
2015-01-01 to 2015-03-31-8,367,611USD90
2014-01-01 to 2014-12-31-39,495,961USD365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2016-12-31124,597,233USD
At 2015-12-31171,850,938USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2016-12-3143,823,027USD
At 2015-12-3131,466,406USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2016-12-3110,513,371USD
At 2015-12-3110,113,371USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2016-12-317,628,394USD
At 2015-12-313,905,860USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2016-12-3115,821,511USD
At 2015-12-317,299,612USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2016-10-01 to 2016-12-3130,877,248USD92
2016-01-01 to 2016-12-31111,604,298USD366
2016-07-01 to 2016-09-3032,735,946USD92
2016-04-01 to 2016-06-3024,430,331USD91
2016-01-01 to 2016-03-3123,560,773USD91
2015-10-01 to 2015-12-3120,461,977USD92
2015-01-01 to 2015-12-3174,855,813USD365
2015-07-01 to 2015-09-3020,452,817USD92
2015-04-01 to 2015-06-3020,406,771USD91
2015-01-01 to 2015-03-3113,534,248USD90
2014-01-01 to 2014-12-3149,952,727USD365

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2016-10-01 to 2016-12-3123,911,731USD92
2016-01-01 to 2016-12-3188,712,035USD366
2016-07-01 to 2016-09-3026,980,343USD92
2016-04-01 to 2016-06-3019,630,801USD91
2016-01-01 to 2016-03-3118,189,160USD91
2015-10-01 to 2015-12-3115,601,891USD92
2015-01-01 to 2015-12-3157,791,923USD365
2015-07-01 to 2015-09-3016,075,201USD92
2015-04-01 to 2015-06-3016,688,511USD91
2015-01-01 to 2015-03-319,426,320USD90
2014-01-01 to 2014-12-3134,095,039USD365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2016-12-3174,062,370shares
At 2015-12-3172,217,965shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2016-12-31556,718,356USD
At 2015-12-31534,004,564USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2016-12-311,327,968USD
At 2015-12-312,708,339USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2016-12-31123,378,420USD
At 2015-12-31175,933,053USD
At 2014-12-31111,537,594USD
At 2013-12-3152,902,683USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2016-12-3114,281,627USD
At 2015-12-3110,854,377USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2016-12-315,256,181USD
At 2015-12-313,547,682USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2016-12-317,628,394USD
At 2015-12-313,905,860USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2016-12-312,113,147USD
At 2015-12-31670,833USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2016-12-316,368,389USD
At 2015-12-312,600,483USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2016-12-311,749,059USD
At 2015-12-31917,257USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

PeriodValueUnitDays
At 2016-12-314,751,000USD
At 2015-12-316,119,000USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2016-10-01 to 2016-12-31-26,233,470USD92
2016-01-01 to 2016-12-31-73,740,339USD366
2016-07-01 to 2016-09-30-20,759,338USD92
2016-04-01 to 2016-06-30-18,704,711USD91
2016-01-01 to 2016-03-31-8,042,820USD91
2015-10-01 to 2015-12-31-18,260,565USD92
2015-01-01 to 2015-12-31-31,200,603USD365
2015-07-01 to 2015-09-303,805,222USD92
2015-04-01 to 2015-06-30-6,162,389USD91
2015-01-01 to 2015-03-31-10,582,871USD90
2014-01-01 to 2014-12-31-36,140,133USD365

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2016-01-01 to 2016-12-31-73,740,339USD366
2015-10-01 to 2015-12-31-17,952,045USD92
2015-01-01 to 2015-12-31-29,102,837USD365
2015-07-01 to 2015-09-305,594,468USD92
2015-04-01 to 2015-06-30-6,162,389USD91
2015-01-01 to 2015-03-31-10,582,871USD90
2014-01-01 to 2014-12-31-36,140,133USD365

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2016-01-01 to 2016-12-31-75,120,710USD366
2015-01-01 to 2015-12-31-26,143,108USD365
2014-01-01 to 2014-12-31-36,315,158USD365

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2016-01-01 to 2016-12-31-73,740,339USD366
2015-01-01 to 2015-12-31-29,909,197USD365
2014-01-01 to 2014-12-31-38,302,916USD365

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2016-10-01 to 2016-12-316,965,517USD92
2016-01-01 to 2016-12-3123,892,263USD366
2016-07-01 to 2016-09-305,755,603USD92
2016-04-01 to 2016-06-305,799,530USD91
2016-01-01 to 2016-03-315,371,613USD91
2015-10-01 to 2015-12-314,860,086USD92
2015-01-01 to 2015-12-3118,063,890USD365
2015-07-01 to 2015-09-304,377,616USD92
2015-04-01 to 2015-06-304,718,260USD91
2015-01-01 to 2015-03-314,107,928USD90
2014-01-01 to 2014-12-3115,857,688USD365

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2016-01-01 to 2016-12-311,708,498USD366
2015-01-01 to 2015-12-311,048,431USD365
2014-01-01 to 2014-12-31626,554USD365

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2016-01-01 to 2016-12-311,377,466USD366
2015-01-01 to 2015-12-31870,199USD365
2014-01-01 to 2014-12-31942,719USD365

Current income tax expense or benefit

Income tax expense or benefit for the period that is currently payable or refundable. It differs from cash taxes paid and from total tax expense.

PeriodValueUnitDays
2016-01-01 to 2016-12-310USD366
2015-01-01 to 2015-12-310USD365
2014-01-01 to 2014-12-312,000USD365

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2016-01-01 to 2016-12-310USD366
2015-01-01 to 2015-12-31-2,098,000USD365
2014-01-01 to 2014-12-3127,000USD365

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2016-01-01 to 2016-12-316,295,761USD366
2015-01-01 to 2015-12-3181,902,363USD365
2014-01-01 to 2014-12-3159,209,182USD365

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2016-01-01 to 2016-12-318,521,899USD366
2015-01-01 to 2015-12-314,497,225USD365
2014-01-01 to 2014-12-31-499,176USD365

Inspect the source

Entity
INOVIO PHARMACEUTICALS, INC. / CIK 0001055726
Captured
2026-09-20T05:17:43.559Z
SEC response SHA-256
9bfa830827e08b2d190e6d0b4ce0274a3c0d8852b6e536b16b5cfeadcaa54cf9

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001055726.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))